Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 28, 46 Issues, 2022
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access

Contents

Current Pharmaceutical Design , Volume 22 - Number 42



Review Article

Adolescent Cannabis Use: What is the Evidence for Functional Brain Alteration?

, 22(42): 6353 - 6365

Valentina Lorenzetti, Silvia Alonso-Lana, George J. Youssef, Antonio Verdejo-Garcia, Chao Suo, Janna Cousijn, Michael Takagi, Murat Yücel and Nadia Solowij


DOI: 10.2174/1381612822666160805155922







Review Article


Review Article

From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We?

, 22(42): 6426 - 6433

Pellegrino Lippiello, Simona Balestrini, Antonio Leo, Antonietta Coppola, Rita Citraro, Maurizio Elia, Emilio Russo and Giovambattista De Sarro


DOI: 10.2174/1381612822666160831122722



Review Article

Circulating microRNAs as Potential Diagnostic, Prognostic and Therapeutic Targets in Pancreatic Cancer

, 22(42): 6444 - 6450

Safieh Ebrahimi, Mina Hosseini, Faezeh Ghasemi, Soodabeh Shahidsales, Mina Maftouh, Hamed Akbarzade, Seyed Ali Reza Parizadeh, Seyed Mahdi Hassanian and Amir Avan


DOI: 10.2174/1381612822666160817095047






Editor-in-Chief

Alessandro Antonelli
(12,288 citations)
Department of Clinical and Experimental Medicine
Laboratory of Primary Human Cells
University of Pisa
Pisa
(Italy)
Biography
View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

COPE Compliant

Cope Logo

Journal History

Current Pharmaceutical Design was introduced in 1995. Prof. Alessandro Antonelli serves as the Editor-in-Chief of the journal.

Advertisement

Jan-2022-banMechanisms-of-Metabolic-Disorders-(MMD)

Related Journals

Related eBooks

eBooks Catalog